Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Dropbox Inc DBX

Dropbox, Inc. provides a content collaboration platform in the United States and internationally. The company’s platform enables individuals, families, teams, and organizations to collaborate for free through its website or app, or through a paid subscription plan for premium features. Its platform consists of various elements, such as unified home for content, global sharing network, and... see more

Opinion & Analysis (NDAQ:DBX)

No current opinion is available.

Bullboard Posts (NDAQ:DBX)

Dropbox (NASDAQ:DBX): A Promising Shift Towards AI-Powered P

http://beyondspx.com/2024/07/31/dropbox-nasdaqdbx-a-promising-shift-towards-ai-powered-productivity/
MikeTester - August 2, 2024

Kevin Harrington Discusses FSD Pharma

<< View Post To Watch Video >> I believe this new product will aid society in reducing the number of alcohol-related...
GraceLee - April 13, 2023

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

 
GraceLee - July 15, 2022

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

<< View Post To Watch Video >>
GraceLee - June 3, 2022

FSD Pharma Files Investigational New Drug Application “IND”

GraceLee - June 2, 2022

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

 
GraceLee - May 11, 2022